Renal atrophy following gated delivery of stereotactic ablative radiotherapy to adrenal metastases

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Stereotactic ablative radiotherapy (SABR) planning for adrenal metastases aims to minimize doses to the adjacent kidney. Renal dose constraints for SABR delivery are not well defined. In 20 patients who underwent MR-guided breath-hold SABR in five daily fractions of 8–10 Gy, ipsilateral renal volumes receiving ≥20 Gy best correlated with loss of renal volumes, with median renal volume reduction being 6% (range: 3%-11%, 10th-90th percentiles). Organ function did not deteriorate in 18 patients, who had post treatment renal function tests available. This suggests that the ipsilateral renal volume receiving 20 Gy can be used as partial organ dose constraint for SABR to targets in the upper abdomen.
Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalPhysics and Imaging in Radiation Oncology
Volume20
DOIs
Publication statusPublished - 1 Oct 2021

Cite this